A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/675 (2006.01) A61K 31/66 (2006.01)
Patent
CA 2223400
Bisphosphonate, particularly alendronate, can prevent or treat bone loss associated with immunosuppressive therapy, whether or not the immunosuppressive therapy is associated with an organ transplant.
Les bisphosphonates, en particulier l'alendronate, peuvent prévenir ou traiter la déperdition osseuse liée à une thérapie d'immunodépression, que cette thérapie soit ou non associée à une transplantation d'organe.
Daifotis Anastasia G.
Yates Ashley John
Gowling Lafleur Henderson Llp
Merck & Co. Inc.
LandOfFree
Bisphosphonates prevent bone loss associated with... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bisphosphonates prevent bone loss associated with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bisphosphonates prevent bone loss associated with... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2088282